JP Morgan Chase’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-53,492
| Closed | -$1.44M | – | 7470 |
|
|
2022
Q4 | $1.44M | Sell |
53,492
-134,022
| -71% | -$3.53M | ﹤0.01% | 3814 |
|
|
2022
Q3 | $3.37M | Sell |
187,514
-46,877
| -20% | -$748K | ﹤0.01% | 3063 |
|
|
2022
Q2 | $2.91M | Buy |
234,391
+218,733
| +1,397% | +$2.41M | ﹤0.01% | 3245 |
|
|
2022
Q1 | $208K | Buy |
15,658
+830
| +6% | +$11.1K | ﹤0.01% | 5173 |
|
|
2021
Q4 | $230K | Buy |
14,828
+1,360
| +10% | +$26K | ﹤0.01% | 5276 |
|
|
2021
Q3 | $302K | Buy |
13,468
+312
| +2% | +$6.85K | ﹤0.01% | 5013 |
|
|
2021
Q2 | $299K | Buy |
13,156
+860
| +7% | +$18.1K | ﹤0.01% | 5018 |
|
|
2021
Q1 | $253K | Buy |
12,296
+9,140
| +290% | +$208K | ﹤0.01% | 5056 |
|
|
2020
Q4 | $87K | Buy |
3,156
+461
| +17% | +$8.97K | ﹤0.01% | 5036 |
|
|
2020
Q3 | $42K | Sell |
2,695
-393
| -13% | -$7.31K | ﹤0.01% | 4993 |
|
|
2020
Q2 | $63K | Sell |
3,088
-1,308
| -30% | -$17.8K | ﹤0.01% | 4748 |
|
|
2020
Q1 | $34K | Sell |
4,396
-2,011
| -31% | -$22.6K | ﹤0.01% | 4835 |
|
|
2019
Q4 | $99K | Sell |
6,407
-249,170
| -97% | -$2.51M | ﹤0.01% | 4906 |
|
|
2019
Q3 | $1.33M | Buy |
255,577
+143,216
| +127% | +$1.06M | ﹤0.01% | 3674 |
|
|
2019
Q2 | $1.04M | Buy |
112,361
+28,941
| +35% | +$432K | ﹤0.01% | 3845 |
|
|
2019
Q1 | $1.99M | Sell |
83,420
-38,444
| -32% | -$786K | ﹤0.01% | 3334 |
|
|
2018
Q4 | $2M | Buy |
121,864
+30,269
| +33% | +$597K | ﹤0.01% | 3274 |
|
|
2018
Q3 | $2.43M | Sell |
91,595
-32,068
| -26% | -$726K | ﹤0.01% | 3318 |
|
|
2018
Q2 | $2.83M | Buy |
123,663
+16,719
| +16% | +$365K | ﹤0.01% | 3138 |
|
|
2018
Q1 | $2.27M | Buy |
106,944
+6,263
| +6% | +$95.3K | ﹤0.01% | 3183 |
|
|
2017
Q4 | $1.27M | Buy |
100,681
+9,468
| +10% | +$127K | ﹤0.01% | 3581 |
|
|
2017
Q3 | $1.38M | Buy |
91,213
+14,203
| +18% | +$173K | ﹤0.01% | 3350 |
|
|
2017
Q2 | $901K | Sell |
77,010
-6,060
| -7% | -$75.1K | ﹤0.01% | 3481 |
|
|
2017
Q1 | $975K | Buy |
83,070
+19,474
| +31% | +$223K | ﹤0.01% | 3431 |
|
|
2016
Q4 | $791K | Buy |
+63,596
| New | +$737K | ﹤0.01% | 3548 |
|
Other funds holding MYOV
JP Morgan Chase's MYOV Position: Q1 2023 in Review
JP Morgan Chase sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 53,492 shares — an estimated $1.44M sold.
JP Morgan Chase first reported a position in MYOV in Q4 2016 and held it in 25 quarters. The position peaked at $3.37M in Q3 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.
- JP Morgan Chase reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
- JP Morgan Chase sold 53,492 Myovant Sciences Ltd. shares in Q1 2023, an estimated $1.44M.
- JP Morgan Chase first reported a position in Myovant Sciences Ltd. in Q4 2016 and held it in 25 quarters.
- JP Morgan Chase's Myovant Sciences Ltd. position peaked at $3.37M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.